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Introduction
In response to members’ significant concerns and their
request for an examination of the evidence relating to
oropharyngeal dysphagia assessment, aerosol-generating
procedures (AGPs) and associated risk of COVID-19
infection, the Royal College of Speech and Language
Therapists (RCSLT) established a COVID-19 Advisory
Group (see the appendix). The group aimed to review
the evidence underpinning the current healthcare
policies in relation to AGPs, dysphagia assessment, and
risk of transmission of and infection with COVID-19
in response to urgent clinical information needs.
Dysphagia assessment
Oropharyngeal dysphagia assessment is highly complex
and may comprise a wide spectrum of interventions
including, but not limited to, clinical (bedside) swal-
lowing assessment, provision of therapeutic oral care,
fibreoptic endoscopic evaluation of swallowing, vide-
ofluoroscopy swallowing study and cough reflex testing.
In the UK, dysphagia assessment is often conducted by
speech and language therapists (SLTs), though interna-
tionally (particularly in regions with no access to SLTs),
other multidisciplinary team members may be respon-
sible for this aspect of healthcare. Dysphagia screening
will often draw on the skills of the wider multidisci-
plinary team with specialist nurses in acute stroke and
stroke rehabilitation settings, for example, undertaking
dysphagia screenings while SLTs undertake in depth
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dysphagia assessment and a more consultative role (Mar-
tino et al. 2014). Dysphagia assessment occurs in a range
of clinical contexts where there are concerns about a pa-
tient’s swallowing ability, including acute and critical
care, outpatient departments, rehabilitation units, and
community settings.
Review methods
The rapid review focused on clinical (bedside) swallow-
ing assessment and the risk of COVID-19 transmission
through aerosol emissions, the likelihood of aerosol
emissions during dysphagia assessment and the evidence
supporting the identification of the AGPs identified
in COVID-19 healthcare recommendations. While a
standard systematic review approach is preferable when
establishing an evidence base for a defined intervention,
this was not feasible in the context of the COVID-19
pandemic for several reasons. COVID-19 is a novel
virus, distinct in many ways from other viral respiratory
infections such as Severe Acute Respiratory Syndrome
(SARS) or Middle East Respiratory Syndrome (MERS)
(Wölfel et al. 2020). It was first reported in December
2019 in Wuhan, China, a country where the SLT
profession is in its infancy. Early evidence specific to
COVID-19 and dysphagia assessment was anticipated
to be scarce. The pace of newly emerging COVID-19 lit-
erature and daily updates to national healthcare policies
and recommendations resulted in a rapidly changing
literature base which made a traditional in-depth
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systematic review approach unfeasible. Conducting a
wider systematic search with broader inclusion criteria,
such as ‘viral transmission’ and ‘infection rates’ and
‘coughing’ alone, for example, generated a greater num-
ber of references (but many irrelevant references based
on pilot search strategies), take considerably more time
to review and evaluate, but generate findings of question-
able relevance to COVID-19 and the purposes of this
review.
Search strategy
Our rapid review methodology identified relevant liter-
ature through a narrow search strategy applied to the
following databases (Medline, Embase, Global Health
via Ovid and CINAHL via HDAS) using search strate-
gies specific to the electronic database, but searching
the following keywords (and variations) ‘infection trans-
mission’, ‘infection control’, ‘healthcare workers’ and
‘procedures’ or ‘dysphagia assessment’ and for free-text
terms ‘aerosol generating procedures’ or ‘bio aerosols’
and ‘healthcare workers’ (for a Medline search strategy
example, see the Supplementary Materials). Grey litera-
ture sources NICE Evidence, Oxford CEBM COVID-
19 Evidence Service and MedRxiv were also searched.
We hand-searched JAMA, The Lancet and BMJ since
December 2019, the UK Public Health England and
Health Protection Scotland COVID-19 policy docu-
ments and references cited in those documents, and em-
ployed backwards citation searching of key papers iden-
tified in the search. We also used PubMed and Google
search engines and communicated with the members
of the RCSLT COVID-19 Advisory Group and other
international experts.
Inclusion criteria
We included information relating to COVID-19 and
dysphagia assessment, aerosol generation, risk of infec-
tion, transmission, coughing and SLTs. We also reviewed
the underpinning evidence informing Public Health
England and Health Protection Scotland lists of AGPs
and risk of viral transmission or infection and consid-
ered to what extent SLTs or dysphagia assessment were
included in that evidence base.
All authors reviewed the literature, sharing their
findings and supporting references with co-authors
electronically. Through an iterative process, the search
findings were collated and summarized with queries,
clarifications or explanations. Remaining queries or
discrepancies were resolved in a final videoconference
discussion between all co-authors. An initial draft of
the final review findings was shared with the wider
COVID-19 Advisory Group for review and feedback.
COVID-19 and routes of transmission
The World Health Organisation (WHO) recently con-
cluded that, based on the current evidence, transmission
of COVID-19 is primarily through respiratory droplets
and contact routes (Modes of Transmission of Virus Caus-
ing COVID-19: Implications for IPC Precaution Recom-
mendations 2020). A high viral load has been detected in
the saliva of patients with COVID-19 with viral shed-
ding observed up to 11 days after hospital admission
(To et al. 2020b) and in a follow-up study, up to 25 days
after symptom onset (To et al. 2020a). Viral shedding
from throat swabs is reported for a median of 20.0 days
(interquartile range (IQR) = 17.0–24.0) n = 137 sur-
vivors) and up to 37 days following symptom onset or
until death (n = 54) (Zhou et al. 2020). Research sug-
gests that patients with severe COVID-19, such as those
who are critically ill, have a higher viral load and shed
the virus for longer (Liu et al. 2020). Emission of respi-
ratory droplets has been acknowledged as an important
route of COVID-19 transmission (Guidance: Transmis-
sion Characteristics and Principles of Infection Prevention
and Control 2020, To et al. 2020a).
COVID-19 transmission and aerosols
International and national COVID-19 policy and prac-
tice recommendations consistently highlight the emis-
sion of very small droplets (aerosols) from COVID-
19 positive patients as increasing the risk of airborne
transmission (Infection Prevention and Control and Pre-
paredness for COVID-19 in Healthcare Settings. Second
Update—31 March 2020 2020, COVID-19 Personal
Protective Equipment (PPE) 2020). Aerosols may remain
suspended in the air for a period of time, travel over
a distance and may cause infection if inhaled (Aerosol
Generating Procedures (AGPs) 2019).
Aerosol emissions and coughing
The dichotomous definition of aerosols and droplets is
an arbitrary one, based on droplet size rather than a for-
mal measure of infection risk or transmission rate (Shiu
et al. 2019, Bourouiba 2020). The boundary of distinc-
tion varies across the literature (Howard et al. 2020).
In realistic contexts, respiratory droplet emissions from
a cough or a sneeze form a complex cluster of droplets
across a range of sizes and from different levels of the res-
piratory system, within a turbulent gas cloud, under for-
ward momentum (Bourouiba et al. 2014). In contrast to
laboratory-based investigations of isolated droplets, the
distance travelled by droplets emitted on a cough varies
depending on a range of contextual factors: the patient’s
physiology, air flow currents, humidity and tempera-
ture (Zhu et al. 2006, Bourouiba et al. 2014). Other
AGPs, dysphagia assessment and COVID-19: A rapid review 631
droplets may evaporate and remain suspended in the air
for hours (Bourouiba et al. 2014). Coughing is an ac-
knowledged source of aerosol droplet emissions (Aerosol
Generating Procedures (AGPs) 2019, Guidance: Transmis-
sion Characteristics and Principles of Infection Prevention
and Control 2020, Infection Prevention and Control and
Preparedness for COVID-19 in Healthcare Settings. Sec-
ond Update—31 March 2020 2020, Greenhalgh 2020,
Howard et al. 2020) and saliva droplets emitted during
forceful coughing have been highlighted as an impor-
tant route for virus transmission (Judson and Munster
2019, Zhu et al. 2006).
Swallowing (dysphagia) assessment and
coughing
Dysphagia assessment comprises several components, of
which cough testing (voluntary cough), reflexive cough
and swallowing trials with samples of fluid and food
are of particular relevance to this report (Martino et al.
2004, Watts et al. 2016). Reflexive coughing, secondary
to aspiration of food or fluid into the lungs, is a com-
mon but unpredictable occurrence inherent to special-
ist dysphagia assessment (Smith Hammond and Gold-
stein 2006). The resultant coughing may be forceful,
prolonged and not easily suppressed (Mazzone 2005,
Addington et al. 2008; expert opinion of the Advisory
Group). In addition, many dysphagia assessment pro-
tocols include some form of testing the presence and
strength of a patients’ voluntary cough as an indicator
of their ability to protect their airway from aspiration
of food or fluids (Watts et al. 2016). Undertaken by
SLTs within 1 m of the patient, comprehensive dyspha-
gia assessments are prolonged, lasting close to 10 min
during which time coughing is tested or expected to oc-
cur (expert opinion of the Advisory Group). Ear, nose
and throat (ENT) healthcare professionals have been re-
ported to be at high risk of exposure and infection from
COVID-19 due to their close proximity to patients’ up-
per respiratory mucosa and interventional procedures
that, similar to dysphagia assessments, induce cough
(Givi et al. 2020, Lu et al. 2020). Given the proximity
and prolonged exposure to frequent coughing during
dysphagia assessment and strong theoretical risks, it is a
reasonable assumption that SLTs are at a similarly high
level of occupational risk of COVID-19 infection.
Dysphagia-induced coughing and patients
with COVID-19
Clinically, many patients presenting with COVID-19
(or suspected COVID-19) and dysphagia are predis-
posed to coughing during dysphagia assessments as
a result of their concomitant respiratory conditions:
upper respiratory tract symptoms of the COVID-19
infection, respiratory support requirements (Leder et al.
2015, Oomagari et al. 2015, Hori et al. 2016, Jaffe et al.
2018), reduced oxygen saturations (Steele and Cichero
2014), post-acute respiratory distress syndrome (Brod-
sky et al. 2017) or other comorbidities (e.g., chronic
obstructive pulmonary disorder; Cvejic et al. 2011).
Dysphagia itself may have resulted in an aspiration
pneumonia while oral, pharyngeal and laryngeal weak-
ness (secondary to intubation, intensive care unit (ICU)
acquired weakness or neurological conditions) reduces
the patients’ ability to manage oral secretions and pro-
tect the airway (Scheel et al. 2016, Brodsky et al. 2017).
Thus, patients presenting with COVID-19 and dyspha-
gia are predisposed to a heightened and more frequent
coughing through aspiration of saliva, food or liquids.
Aerosol-generating procedures (AGPs)
AGPs are defined as ‘any medical and patient care proce-
dure that results in the production of airborne particles
(aerosols)’ (Aerosol Generating Procedures (AGPs), 2020).
At the time of writing, there is no consensus on a defini-
tive list of healthcare procedures that are AGPs (Judson
and Munster 2019) with variations in medical and care
procedures considered to be AGPs across national poli-
cies (table 1) (Thompson et al. 2013, Shiu et al. 2019,
Use of PPE to Support Infection Prevention and Control
Practice when Performing Aerosol Generating Procedures
on Confirmed or Clinically Suspected COVID-19 Cases
in a Pandemic Situation 2020). One recent review dis-
tinguished between AGPs that resulted in the creation
or dispersion of aerosols and procedures that induced a
patient to produce them (Judson and Munster 2019).
Where possible, research evidence relating to acute
respiratory infection transmission from patients to
healthcare professionals in the context of specific health-
care procedures is used to identify AGP considered
to be at high risk (Infection Prevention and Control of
Epidemic- and Pandemic-Prone Acute Respiratory Infec-
tions in Health Care 2014). The evidence base is limited,
however, and biased in the selection of procedures in-
vestigated as sources of transmission (Tran et al. 2012,
Thompson et al. 2013) later synthesized in reviews
and meta-analyses and, in turn, underpinning clinical
recommendations.
Recent WHO guidelines on infection preven-
tion and control (Infection Prevention and Control of
Epidemic- and Pandemic-Prone Acute Respiratory Infec-
tions in Health Care 2014), for example, refer to a sys-
tematic review in support of their classification of AGP
and increased risk of SARS infection transmission (Tran
et al. 2012). The systematic reviewers, however, used
an earlier WHO-generated list of AGPs to inform their
review inclusion criteria. The reviewers highlight the
lack of information available on procedures known to
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induce coughing and associated aerosol emissions and
the possible risk of infection transmission associated
with those procedures (Tran et al. 2012). Thus, as stated
by the Centers for Disease Control and Prevention:
‘there is neither expert consensus, nor sufficient sup-
porting data, to create a definitive and comprehensive
list of AGPs for healthcare settings’ (Healthcare Infection
Prevention and Control FAQs for COVID-19 2020).
New AGPs continue to be identified through liter-
ature reviews of conflicting studies, theoretical risk of
aerosol generation and expert consensus; non-invasive
ventilation and high flow nasal oxygen, for example, are
two recent inclusions in UK health protection policy
documents (Aerosol Generating Procedures (AGPs) 2019).
The research evidence to date on the risk of infec-
tion and transmission rate has focused on predefined
AGPs. Within the systematic review of AGPs and risk
of SARS transmission (Tran et al. 2012) all 10 included
studies focused on intubation and ventilation proce-
dures conducted by medical and/or nursing staff. Half
did not appear to include SLTs; three of 10 studies fo-
cused on intubation and tracheostomy procedures only;
two of 10 were specific to nursing or medical staff only.
The remaining five studies (n = 1764 staff participants)
referred to ‘other staff’ (n = 150), but no SLTs were
described, nor was dysphagia assessment. Three studies
recorded healthcare professionals’ contact with patient
sputum and/or respiratory secretions, each reporting a
significantly increased risk of infection. The quality of
the primary research studies was poor, and the review
syntheses were rated as low quality (Tran et al. 2012). As
another example, a recent cluster randomized controlled
trial evaluated the effectiveness of N95 respirators versus
medical masks in reducing the risk of influenza trans-
mission to healthcare professionals (Radonovich et al.
2019). The large trial took place across several US out-
patient settings where dysphagia assessment is likely to
be rare. SLTs were unreported amongst the 16 pro-
fessionals recorded in the trial staff participant record
form. The AGP recorded as undertaken by the staff in-
cluded: intubation, respiratory/airway suctioning, neb-
ulizer treatments and nasopharyngeal aspiration. While
some research on AGP and risk of transmission exists,
the evidence relating to dysphagia assessment and risk is
absent, though this does not reflect an absence of risk.
Procedures which induce forceful coughing
Induction of sputum following the administration of
saline into the lungs, moistening and loosening respi-
ratory secretions, shares an infection risk profile similar
to dysphagia induced, prolonged and forceful cough-
ing when food or fluid is aspirated into the lungs. The
induction of sputum is currently considered an AGP
(Aerosol Generating Procedures (AGPs) 2019). The recent
European Centre for Disease Prevention and Control
recommendations (Infection Prevention and Control and
Preparedness for COVID-19 in Healthcare Settings. Second
Update—31 March 2020 2020) highlighted the risk of
coughing or sneezing induced while collecting nasopha-
ryngeal diagnostic respiratory samples, and the associ-
ated risk of aerosol production. Thus, there is consensus
across the healthcare and infection control community
that procedures known to induce prolonged and force-
ful coughing result in the production of aerosols which
in turn place healthcare professionals at greater risk of
infection. There is general agreement across the liter-
ature and guidelines that in such cases precautionary
steps should be taken to reduce the risk of infection for
healthcare professionals.
Conclusions
We have presented evidence that forceful coughing gen-
erates aerosols and the emerging evidence which in-
dicates that COVID-19 is likely transmitted through
aerosol (and other) routes. We described SLTs’ close and
prolonged contact with forceful coughing, induced dur-
ing standard dysphagia assessment procedures and why
patients with COVID-19 are likely to be at greater risk
of coughing. We examined the criteria used to establish
the current list of AGP and found a lack of consen-
sus and a high risk of selection bias, focusing only on
risk of infection based on previously identified AGPs.
We highlighted evidence that suggests a greater risk of
transmission and infection of healthcare professionals
that experience frequent and repeated contact with pa-
tients’ respiratory secretions or sputum in the context of
a novel virus, non-immunity and high infectivity.
Amongst the limitations of our rapid review is the
depth of searching and analysis of primary research find-
ings that could be undertaken within a short timeframe.
We were unable to identify definitive evidence linking
dysphagia assessment to a higher risk of COVID-19
transmission. However, it is important to note that we
also failed to identify evidence that the procedure does
not increase the risk of transmission. The strength of
our rapid review includes the expert dysphagia author-
ship informed by a UK-wide expert advisory group, a
thorough search of published and grey literature, under-
taken in a timely manner to address an urgent clinical
question in the context of the COVID-19 pandemic.
We presented strong theoretical reasons and un-
derpinning empirical evidence to support our recom-
mendation: that dysphagia assessment is considered an
AGP. The following multidisciplinary professional asso-
ciations and learned societies, which share our interest
in this issue, are in support of our conclusions (see the
Supplementary Materials):
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 British Association of Parenteral and Enteral Nu-
trition.
 British Thoracic Society.
 British Association of Stroke Physicians.
 ENT-UK.
 European Society of Swallowing Disorders.
 Intensive Care Society, National Tracheostomy
Safety Project.
 UK Swallowing Research Group.
In the context of the available evidence and expert
consensus, healthcare providers and infection control
policy-makers should take precautionary steps to reduce
the risk of COVID-19 transmission and infection while
undertaking dysphagia procedures (Infection Prevention
and Control and Preparedness for COVID-19 in Health-
care Settings. Second Update—31 March 2020 2020).
The safety of healthcare workers and expert consensus
should prevail.
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